Reassessing the positive community D-dimer: can we safely reduce imaging? Authors: Jeremy Furyk, Colin Banks Published: 2026 The diagnostic approach to suspected pulmonary embolism (PE) in the emergency department (ED) is among the most well-studied in acute care medicine [1]. Diagnostic pathways are well established, incorporating a structured assessment of pretest probability, followed by PE rule-out criteria or D-dimer testing, with definitive imaging reserved for patients who remain at sufficient risk [1]. These evidence-based algorithms have substantially reduced unnecessary imaging while maintaining patient safety. When patients present to the ED with an elevated community D-dimer, the community practitioner may use different D-dimer thresholds; it may be unclear whether an appropriate pretest probability assessment was performed and whether the community D-dimer assay used is comparable. In this issue of Research and Practice in Thrombosis and Haemostasis, Bittermann et al. [2] address this important clinical dilemma by proposing a reassessment strategy for patients presenting with an elevated community D-dimer. This is a timely contribution to a problem that contributes to ED workload, overcrowding, and prolonged patient stays, resulting in unnecessary imaging, overdiagnosis, and incidental findings, all of which carry important patient and healthcare costs. The authors propose a pragmatic 3-step reassessment strategy: 1) reassessment of clinical probability, including application of the PE rule-out criteria as appropriate; 2) interpretation of the community D-dimer using YEARS or age-adjusted thresholds; 3) repeat D-dimer testing in the ED using the VIDAS assay (bioMerieux) for those with a D-dimer remaining above the adjusted thresholds. The primary objective was to determine whether this approach could reduce the need for chest imaging. Using prospectively collected data from 2 French EDs, the authors retrospectively applied their proposed algorithm to 75 adults presenting with elevated community D-dimer results. Application of the reassessment strategy would have reduced chest imaging by 49%, meeting the study’s primary objective. However, this reduction came at the cost of 1 missed PE, corresponding to a strategy failure rate of 1% (95% CI, 0%-7%). Although the point estimate appears acceptable, the upper confidence limit substantially exceeds accepted safety thresholds for PE diagnostic strategies and reflects the uncertainty inherent in the small sample size. This study [2] has several notable strengths. Data were collected prospectively, reflecting real-world ED practice, and the authors addressed a clinically important question that has received little previous attention. Nevertheless, several important limitations warrant caution. First, this was an observational analysis in which the proposed algorithm was applied retrospectively rather than prospectively to guide clinical care. As with any retrospective application of a decision rule, important sources of bias cannot be excluded. Second, the study was small, resulting in wide CIs around estimates of diagnostic safety. For PE diagnostic strategies, narrow CIs are essential because even small increases in missed diagnoses can have significant clinical consequences. Third, the study population differs from those used to derive and validate existing diagnostic algorithms. Patients presenting with an elevated community D-dimer constitute an inherently selected population and likely have a higher pretest probability of PE. Interestingly, community D-dimer values tended to be higher than those in ED assays, supporting the idea that applying YEARS and age-adjusted thresholds may be appropriate in this setting. However, the authors also acknowledge previous evidence suggesting that the failure rate of YEARS may be higher among patients referred to the ED with suspected PE, reinforcing the need for caution. Perhaps the greatest limitation is the lack of systematic follow-up. Without complete follow-up, patients who were not imaged could not be confidently classified as free of PE, limiting conclusions about diagnostic safety. In addition, there is concern that PE may have been overdiagnosed, and the presence of PE on a scan is less patient-focused than follow-up for those who were not scanned. Finally, imaging decisions and clinical probability assessments were made by treating emergency physicians who were aware of the positive community D-dimer result. This knowledge almost certainly influenced clinical judgment and imaging decisions. While this introduces bias, it also reflects everyday practice and highlights the cognitive challenge clinicians face when confronted with an abnormal test result obtained before formal risk assessment. Beyond diagnostic performance, an additional consideration is maintaining confidence in primary care assessment. Strategies that routinely disregard community investigations risk undermining continuity between primary and emergency care, whereas unquestioning acceptance of all community D-dimer results may lead to unnecessary imaging [3]. Finding the appropriate balance remains challenging. The findings should be viewed as exploratory and hypothesis-generating rather than practice-changing. Patients presenting with positive community D-dimer results pose a genuine diagnostic challenge. Clinicians must reconcile patient expectations, variability in D-dimer assays, uncertainty about the original clinical assessment, and differences in laboratory thresholds. Larger prospective studies are needed to evaluate the safety and effectiveness of any reassessment strategy. Such studies should incorporate standardized follow-up, a sufficient sample size to provide precise estimates of failure rates, and further refinement of the algorithm across different D-dimer assays and healthcare settings. Bittermann et al. [2] addressed an important clinical dilemma and proposed a thoughtful strategy that has the potential to substantially reduce unnecessary imaging. However, until prospective validation confirms diagnostic safety, a cautious approach is warranted. Reassessing clinical probability, shared decision-making with patients, and selective avoidance of imaging in carefully selected patients remain the most appropriate approach. Acknowledgments Funding This research recieved no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Author contributions Both authors contributed equally to the conception, development, and preparation of the manuscript. Both authors reviewed and approved the final version. Relationship disclosure The authors declare no conflicts of interst or relevant financial or non-financial relationships. Footnotes Handling Editor: Professor Michael Makris References